Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
- Conditions
- Chronic Kidney DiseaseHeart FailureCardiovascular Risk
- Registration Number
- NCT06122961
- Lead Sponsor
- Novo Nordisk A/S
- Brief Summary
This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease). Participants will continue their normal care and will not get any treatment other than those the study doctor has prescribed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 18198
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method High sensitivity C-reactive protein (hsCRP) greater than or equal to 2 mg/L (yes/ no) At visit (day 0) Count of patient
- Secondary Outcome Measures
Name Time Method N-terminal prohormone of brain natriuretic peptide (NT-proBNP) At visit (day 0) pg/ml
Interleukin 6 (IL-6) At visit (day 0) pg/ml
Trial Locations
- Locations (194)
Mission Cardiovascular Research Institute
🇺🇸Fremont, California, United States
Texas Institute of Cardiology PA
🇺🇸McKinney, Texas, United States
Fundacion Favaloro
🇦🇷Caba, Buenos Aires, Argentina, Argentina
Hospital Italiano Regional Sur
🇦🇷Bahia Blanca, Buenos Aires, Argentina
Clínica Coronel Suarez
🇦🇷Coronel Suarez, Buenos Aires, Argentina
Hospital Italiano de la Plata
🇦🇷La Plata, Buenos Aires, Argentina
Centro Médico CIMEL
🇦🇷Lanus Este, Buenos Aires, Argentina
INECO Neurociencias Oroño
🇦🇷Rosario, Santa Fe, Argentina
DIM Clinica Privada
🇦🇷Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Quilmes SRL
🇦🇷Buenos Aires, Argentina
Scroll for more (184 remaining)Mission Cardiovascular Research Institute🇺🇸Fremont, California, United States